Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes.
Genome-wide association studies have revealed that common noncoding variants in MTNR1B (encoding melatonin receptor 1B, also known as MT(2)) increase type 2 diabetes (T2D) risk(1,2). Although the strongest association signal was highly significant (P < 1 × 10(-20)), its contribution to T2D ri...
Main Authors: | Bonnefond, A, Clément, N, Fawcett, K, Yengo, L, Vaillant, E, Guillaume, J, Dechaume, A, Payne, F, Roussel, R, Czernichow, S, Hercberg, S, Hadjadj, S, Balkau, B, Marre, M, Lantieri, O, Langenberg, C, Bouatia-Naji, N, Charpentier, G, Vaxillaire, M, Rocheleau, G, Wareham, N, Sladek, R, McCarthy, M, Dina, C, Barroso, I |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2012
|
Similar Items
-
Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes
by: Bonnefond, A, et al.
Published: (2012) -
Variants in MTNR1B influence fasting glucose levels.
by: Prokopenko, I, et al.
Published: (2009) -
Common genetic variation near melatonin receptor MTNR1B contributes to raised plasma glucose and increased risk of type 2 diabetes among Indian Asians and European Caucasians.
by: Chambers, J, et al.
Published: (2009) -
B27 Disruption of melatonin circadian rhythmicity in Huntington's disease (HD)
by: Kalliolia, E, et al.
Published: (2012) -
Direct radioimmunoassay for melatonin in plasma.
by: Fraser, S, et al.
Published: (1983)